HL7 BE Laboratory WG Implementation Guide
1.0.0 - STU
HL7 BE Laboratory WG Implementation Guide
1.0.0 - STU
This page is part of the HL7 Belgium FHIR Implementation Guide - Lab related profiles (v1.0.0: Trial Use) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions 
<Bundle xmlns="http://hl7.org/fhir">
<id value="antibiogramAsBundleCollection"/>
<identifier>
<system value="urn:ietf:rfc:3986"/>
<value value="urn:uuid:0c3151bd-1cbf-4d91-b04d-cd9187a4c6e0"/>
</identifier>
<type value="collection"/>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d34"/>
<resource>
<DiagnosticReport>
<id value="diagnosticreport50"/>
<meta>
<versionId value="1"/>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-laboratory-report"/>
</meta>
<language value="en"/>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<identifier>
<system
value="https://www.ehealth.fgov.be/lab-report/diagnostic-report-id"/>
<value value="11530231003.2015110413180000000"/>
</identifier>
<basedOn>
<reference value="ServiceRequest/servicerequest50"/>
</basedOn>
<status value="final"/>
<category>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0074"/>
<code value="LAB"/>
<display value="Laboratory"/>
</coding>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0074"/>
<code value="MB"/>
<display value="Microbiology"/>
</coding>
</category>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="18769-0"/>
<display value="Microbial susceptibility tests Set"/>
</coding>
<text value="Microbial susceptibility tests"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-03T13:18:00+01:00"/>
<issued value="2015-11-04T13:18:00+01:00"/>
<performer>
<reference value="Organization/organization10"/>
</performer>
<resultsInterpreter>
<reference value="Practitioner/practitioner11"/>
</resultsInterpreter>
<specimen>
<reference value="Specimen/specimen50"/>
</specimen>
<result>
<reference value="Observation/org51"/>
</result>
<result>
<reference value="Observation/org52"/>
</result>
<result>
<reference value="Observation/dr50-mrsa"/>
</result>
<result>
<reference value="Observation/dr50-mrgn"/>
</result>
<conclusion value="This is our conclusion"/>
</DiagnosticReport>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d36"/>
<resource>
<Specimen>
<id value="specimen50"/>
<meta>
<versionId value="1"/>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-specimen-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<identifier>
<system value="https://www.GTL-LABO.be/"/>
<value value="1"/>
</identifier>
<status value="available"/>
<type>
<coding>
<system value="http://snomed.info/sct"/>
<code value="258529004"/>
<display value="Throat swab"/>
</coding>
<text value="A string can be added to nuance or explain."/>
</type>
<receivedTime value="2015-11-04"/>
<note>
<text value="Some extra relevant information concerning the specimen"/>
</note>
</Specimen>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d37"/>
<resource>
<Observation>
<id value="org51"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="73960-7"/>
<display value="Bacteria identified in Mouth by Culture"/>
</coding>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="243301005"/>
<display value="Morganella morganii"/>
</coding>
</valueCodeableConcept>
<specimen>
<reference value="Specimen/specimen50"/>
</specimen>
<hasMember>
<reference value="Observation/org51-ampicilin"/>
</hasMember>
<hasMember>
<reference value="Observation/org51-trimethoprim-sulfamethoxazole"/>
</hasMember>
<hasMember>
<reference value="Observation/org51-nitrofurantoin"/>
</hasMember>
<hasMember>
<reference value="Observation/org51-cefuroxime"/>
</hasMember>
<hasMember>
<reference value="Observation/org51-gentamicin"/>
</hasMember>
<hasMember>
<reference value="Observation/org51-colistin"/>
</hasMember>
<hasMember>
<reference value="Observation/org51-temocillin"/>
</hasMember>
<hasMember>
<reference value="Observation/org51-fosfomycin"/>
</hasMember>
<hasMember>
<reference value="Observation/org51-levofloxacin"/>
</hasMember>
<hasMember>
<reference value="Observation/org51-ofloxacin"/>
</hasMember>
<hasMember>
<reference value="Observation/org51-amoxicillin-clavulanate"/>
</hasMember>
<hasMember>
<reference value="Observation/org51-amikacin"/>
</hasMember>
<hasMember>
<reference value="Observation/org51-piperacillin-tazobactam"/>
</hasMember>
<hasMember>
<reference value="Observation/org51-ceftriaxone"/>
</hasMember>
<hasMember>
<reference value="Observation/org51-cefotaxime"/>
</hasMember>
<hasMember>
<reference value="Observation/org51-ceftazidime"/>
</hasMember>
<hasMember>
<reference value="Observation/org51-meropenem"/>
</hasMember>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae01-48abcadd8d38"/>
<resource>
<Observation>
<id value="org51-ampicilin"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="29-9"/>
<display value="Ampicillin [Susceptibility] by Disk diffusion (KB)"/>
</coding>
<text value="Ampicillin"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="R"/>
<display value="Resistant"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae02-48abcadd8d39"/>
<resource>
<Observation>
<id value="org51-trimethoprim-sulfamethoxazole"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="516-5"/>
<display
value="Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Trimethoprim+Sulfamethoxazole"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae03-48abcadd8d40"/>
<resource>
<Observation>
<id value="org51-nitrofurantoin"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="363-2"/>
<display
value="Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Nitrofurantoin"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="R"/>
<display value="Resistant"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae04-48abcadd8d41"/>
<resource>
<Observation>
<id value="org51-cefuroxime"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="51774-8"/>
<display
value="Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Cefuroxime"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="R"/>
<display value="Resistant"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae05-48abcadd8d42"/>
<resource>
<Observation>
<id value="org51-gentamicin"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="267-5"/>
<display
value="Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Gentamicin"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae06-48abcadd8d43"/>
<resource>
<Observation>
<id value="org51-colistin"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="205-5"/>
<display
value="Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Colistin"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="R"/>
<display value="Resistant"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae07-48abcadd8d44"/>
<resource>
<Observation>
<id value="org51-temocillin"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="492-9"/>
<display
value="Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Temocillin"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae08-48abcadd8d45"/>
<resource>
<Observation>
<id value="org51-fosfomycin"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="25653-7"/>
<display
value="Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Fosfomycin"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d46"/>
<resource>
<Observation>
<id value="org51-levofloxacin"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="20396-8"/>
<display
value="levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Levofloxacin"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d47"/>
<resource>
<Observation>
<id value="org51-ofloxacin"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="375-6"/>
<display
value="Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Ofloxacin"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d48"/>
<resource>
<Observation>
<id value="org51-amoxicillin-clavulanate"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="20-8"/>
<display
value="Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Amoxicillin+Clavulanate"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="R"/>
<display value="Resistant"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d49"/>
<resource>
<Observation>
<id value="org51-amikacin"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="12-5"/>
<display
value="Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Amikacin"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d50"/>
<resource>
<Observation>
<id value="org51-piperacillin-tazobactam"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="412-7"/>
<display
value="Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Piperacillin+Tazobactam"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d51"/>
<resource>
<Observation>
<id value="org51-ceftriaxone"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="141-2"/>
<display
value="cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Ceftriaxone"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d52"/>
<resource>
<Observation>
<id value="org51-cefotaxime"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="108-1"/>
<display
value="Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Cefotaxime"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d53"/>
<resource>
<Observation>
<id value="org51-ceftazidime"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="133-9"/>
<display
value="cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Ceftazidime"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d54"/>
<resource>
<Observation>
<id value="org51-meropenem"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="6652-2"/>
<display
value="Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Meropenem"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d55"/>
<resource>
<Observation>
<id value="org52"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="73960-7"/>
<display value="Bacteria identified in Mouth by Culture"/>
</coding>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="112283007"/>
<display value="Escherichia coli"/>
</coding>
</valueCodeableConcept>
<specimen>
<reference value="Specimen/specimen50"/>
</specimen>
<hasMember>
<reference value="Observation/org52-ampicilin"/>
</hasMember>
<hasMember>
<reference value="Observation/org52-trimethoprim-sulfamethoxazole"/>
</hasMember>
<hasMember>
<reference value="Observation/org52-nitrofurantoin"/>
</hasMember>
<hasMember>
<reference value="Observation/org52-cefuroxime"/>
</hasMember>
<hasMember>
<reference value="Observation/org52-gentamicin"/>
</hasMember>
<hasMember>
<reference value="Observation/org52-colistin"/>
</hasMember>
<hasMember>
<reference value="Observation/org52-temocillin"/>
</hasMember>
<hasMember>
<reference value="Observation/org52-fosfomycin"/>
</hasMember>
<hasMember>
<reference value="Observation/org52-levofloxacin"/>
</hasMember>
<hasMember>
<reference value="Observation/org52-ofloxacin"/>
</hasMember>
<hasMember>
<reference value="Observation/org52-amoxicillin-clavulanate"/>
</hasMember>
<hasMember>
<reference value="Observation/org52-amikacin"/>
</hasMember>
<hasMember>
<reference value="Observation/org52-piperacillin-tazobactam"/>
</hasMember>
<hasMember>
<reference value="Observation/org52-ceftriaxone"/>
</hasMember>
<hasMember>
<reference value="Observation/org52-cefotaxime"/>
</hasMember>
<hasMember>
<reference value="Observation/org52-ceftazidime"/>
</hasMember>
<hasMember>
<reference value="Observation/org52-meropenem"/>
</hasMember>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae01-48abcadd8d56"/>
<resource>
<Observation>
<id value="org52-ampicilin"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="29-9"/>
<display value="Ampicillin [Susceptibility] by Disk diffusion (KB)"/>
</coding>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae02-48abcadd8d57"/>
<resource>
<Observation>
<id value="org52-trimethoprim-sulfamethoxazole"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="516-5"/>
<display
value="Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Trimethoprim+Sulfamethoxazole"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae03-48abcadd8d58"/>
<resource>
<Observation>
<id value="org52-nitrofurantoin"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="363-2"/>
<display
value="Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Nitrofurantoin"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae04-48abcadd8d59"/>
<resource>
<Observation>
<id value="org52-cefuroxime"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="51774-8"/>
<display
value="Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Cefuroxime"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae05-48abcadd8d60"/>
<resource>
<Observation>
<id value="org52-gentamicin"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="267-5"/>
<display
value="Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Gentamicin"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae06-48abcadd8d61"/>
<resource>
<Observation>
<id value="org52-colistin"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="205-5"/>
<display
value="Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Colistin"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae07-48abcadd8d62"/>
<resource>
<Observation>
<id value="org52-temocillin"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="492-9"/>
<display
value="Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Temocillin"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae08-48abcadd8d63"/>
<resource>
<Observation>
<id value="org52-fosfomycin"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="25653-7"/>
<display
value="Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Fosfomycin"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d64"/>
<resource>
<Observation>
<id value="org52-levofloxacin"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="20396-8"/>
<display
value="levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Levofloxacin"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d65"/>
<resource>
<Observation>
<id value="org52-ofloxacin"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="375-6"/>
<display
value="Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Ofloxacin"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d66"/>
<resource>
<Observation>
<id value="org52-amoxicillin-clavulanate"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="20-8"/>
<display
value="Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Amoxicillin+Clavulanate"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d67"/>
<resource>
<Observation>
<id value="org52-amikacin"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="12-5"/>
<display
value="Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Amikacin"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d68"/>
<resource>
<Observation>
<id value="org52-piperacillin-tazobactam"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="412-7"/>
<display
value="Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Piperacillin+Tazobactam"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d69"/>
<resource>
<Observation>
<id value="org52-ceftriaxone"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="141-2"/>
<display
value="cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Ceftriaxone"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d70"/>
<resource>
<Observation>
<id value="org52-cefotaxime"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="108-1"/>
<display
value="Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Cefotaxime"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d71"/>
<resource>
<Observation>
<id value="org52-ceftazidime"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="133-9"/>
<display
value="cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Ceftazidime"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd9d72"/>
<resource>
<Observation>
<id value="org52-meropenem"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="6652-2"/>
<display
value="Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
</coding>
<text value="Meropenem"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<interpretation>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<code value="S"/>
<display value="Susceptible"/>
</coding>
</interpretation>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd9d80"/>
<resource>
<Observation>
<id value="dr50-mrsa"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="35492-8"/>
<display
value="Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] in Unspecified specimen by NAA with probe detection"/>
</coding>
<text value="MRSA"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<valueString value="negative"/>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd9d81"/>
<resource>
<Observation>
<id value="dr50-mrgn"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<status value="final"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="78702-8"/>
<display
value="Multiple drug resistant gram negative organism [Identifier] in Unspecified specimen by Culture"/>
</coding>
<text value="MRGN"/>
</code>
<subject>
<reference value="Patient/patient1"/>
</subject>
<effectiveDateTime value="2015-11-04T09:16:00-05:00"/>
<issued value="2015-11-04T09:16:00-05:00"/>
<performer>
<reference value="Practitioner/practitioner11"/>
</performer>
<valueString value="negative"/>
</Observation>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d72"/>
<resource>
<Organization>
<id value="organization10"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/core/StructureDefinition/be-organization"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<identifier>
<use value="official"/>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="MD"/>
<display value="Medical License number"/>
</coding>
</type>
<system
value="https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/nihdi"/>
<value value="81165343998"/>
</identifier>
<active value="true"/>
<type>
<coding>
<system
value="https://www.ehealth.fgov.be/standards/fhir/core/CodeSystem/cd-hcparty"/>
<code value="orglaboratory"/>
</coding>
</type>
<name value="GTL - General Testing Laboratory"/>
<telecom>
<system value="phone"/>
<value value="322675199"/>
<use value="work"/>
</telecom>
<address>
<extension url="http://hl7.org/fhir/StructureDefinition/language">
<valueCode value="nl"/>
</extension>
<use value="work"/>
<type value="both"/>
<text value="Vulcansstraat 120, 1000 Brussel"/>
<line value="Vulcansstraat 120">
<extension
url="http://hl7.org/fhir/StructureDefinition/iso21090-ADXP-streetName">
<valueString value="Vulcansstraat"/>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/iso21090-ADXP-houseNumber">
<valueString value="120"/>
</extension>
</line>
<city value="Brussel"/>
<postalCode value="1000"/>
<country value="BE"/>
</address>
</Organization>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d73"/>
<resource>
<Practitioner>
<id value="practitioner11"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/core/StructureDefinition/be-practitioner"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<identifier>
<use value="official"/>
<system
value="https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/nihdi"/>
<value value="554488997"/>
</identifier>
<name>
<use value="official"/>
<family value="Davoust"/>
<given value="Nicolas"/>
</name>
<telecom>
<system value="email"/>
<value value="nicolas.davoust@gtl.be"/>
<use value="work"/>
</telecom>
<telecom>
<system value="phone"/>
<value value="022675198"/>
<use value="work"/>
</telecom>
<telecom>
<system value="fax"/>
<value value="022675209"/>
<use value="work"/>
</telecom>
</Practitioner>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d74"/>
<resource>
<Patient>
<id value="patient1"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/core/StructureDefinition/be-patient"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<identifier>
<use value="official"/>
<system
value="https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/ssin"/>
<value value="79121137740"/>
</identifier>
<active value="true"/>
<name>
<family value="La Paradisio"/>
<given value="Josephine"/>
<given value="Nessa"/>
</name>
<telecom>
<system value="email"/>
<value value="nessa.laparadisio@belgium.be"/>
</telecom>
<telecom>
<system value="phone"/>
<value value="+322476792979"/>
<use value="mobile"/>
</telecom>
<telecom>
<system value="phone"/>
<value value="+3226718655"/>
<use value="home"/>
</telecom>
<telecom>
<system value="phone"/>
<value value="+322476799"/>
<use value="work"/>
</telecom>
<gender value="female"/>
<birthDate value="1979-12-11">
<extension
url="http://hl7.org/fhir/StructureDefinition/patient-birthTime">
<valueDateTime value="1979-12-11T13:28:17-05:00"/>
</extension>
</birthDate>
<address>
<use value="home"/>
<type value="both"/>
<text value="Sloordelle 42, 1160 Oudergem"/>
<line value="Sloordelle 42"/>
<city value="Oudergem"/>
<postalCode value="1160"/>
<country value="BE"/>
</address>
</Patient>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d75"/>
<resource>
<ServiceRequest>
<id value="servicerequest50"/>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<identifier>
<system value="https://www.GTL-LABO.be/orderingsystem"/>
<value value="12334546"/>
</identifier>
<status value="active"/>
<intent value="order"/>
<category>
<coding>
<system value="http://snomed.info/sct"/>
<code value="108252007"/>
<display value="Laboratory procedure"/>
</coding>
</category>
<subject>
<reference value="Patient/patient1"/>
</subject>
<authoredOn value="2015-11-01T14:41:00+01:00"/>
<requester>
<reference value="Practitioner/practitioner1"/>
</requester>
<specimen>
<reference value="Specimen/specimen50"/>
</specimen>
</ServiceRequest>
</resource>
</entry>
<entry>
<fullUrl value="urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d76"/>
<resource>
<Practitioner>
<id value="practitioner1"/>
<meta>
<profile
value="https://www.ehealth.fgov.be/standards/fhir/core/StructureDefinition/be-practitioner"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">empty</div>
</text>
<identifier>
<use value="official"/>
<system
value="https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/nihdi"/>
<value value="18749704477"/>
</identifier>
<name>
<use value="official"/>
<family value="Pulaski"/>
<given value="Katherine"/>
<suffix value="MD"/>
</name>
<telecom>
<system value="email"/>
<value value="katherine.pulaski@enterprisehospital.be"/>
<use value="work"/>
</telecom>
<telecom>
<system value="phone"/>
<value value="022675198"/>
<use value="work"/>
</telecom>
<telecom>
<system value="fax"/>
<value value="022675209"/>
<use value="work"/>
</telecom>
<address>
<use value="home"/>
<text value="Jupiterlaan 5, 1853 Grimbergen"/>
<line value="Jupiterlaan 5"/>
<city value="Grimbergen"/>
<postalCode value="1853"/>
<country value="BE"/>
</address>
</Practitioner>
</resource>
</entry>
</Bundle>
IG © 2021+ eHealth Platform. Package hl7.fhir.be.lab#1.0.0 based on FHIR 4.0.1. Generated 2022-09-08
Links: Table of Contents |
QA Report
| Issues
